Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01971723
Other study ID # HSC#: 2013.10364
Secondary ID
Status Completed
Phase N/A
First received August 27, 2013
Last updated February 1, 2016
Start date June 2013
Est. completion date December 2015

Study information

Verified date February 2016
Source Florida State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

It has been suggested that high amounts of total serum testosterone levels correlate with higher lean body mass, lowered fat mass, greater muscle strength, and faster recovery. These suggestions drive athletes and body builders to find ways to raise their testosterone levels. Many athletes and bodybuilders look to alternative methods to anabolic steroids in order increase their testosterone levels without legal repercussions or physiological side effects. Herbs and other plant extracts have been introduced as a possible source to naturally boost testosterone levels. Research supporting the use of herbs and plant extracts has been shown to be equivocal. However, evidence in studies with hypogonadal men suggests that longjack root may naturally boost testosterone levels.

Onnit Labs, LLC has packaged this supplement (T+) which claims it can naturally boost testosterone and lower estrogen levels and subsequently improve performance. This product is a powder (11g) that is mixed with 16 oz of water and consumed 20 minutes prior to anaerobic workouts, such as high intensity weight training.

T+ is a multi-ingredient supplement that consists of vitamins B5 and B6, magnesium aspartic acid, mucuna pruriens, longjack root, nettle root, red clover luteolin, resveratrol, beta- alanine, branch chain amino acids, L- glutamine, Bioperine, and Fibersol 2.

The active ingredients purported to boost plasma testosterone levels are mucuna pruriens, longjack root, and magnesium aspartic acid. The active ingredients claimed to lower plasma estrogen concentrations are red clover, luteolin, resveratrol and nettle root. All other ingredients (Branch Chain Amino Acids and Beta-Alanine) have been documented to improve exercise performance.

It is hypothesized that there will not be any physiological changes after supplementation of T+. It is also hypothesized that performance will not be affected by the supplementation of T+.


Description:

The purpose of this study is to examine the physiological and performance effects of T+ on power athletes.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Must be familiar with the three main powerlifting movements (squat, bench and deadlift)

- Must have one month training with a designated strength coach to understand the expectations of the strength coach and movement patterns for performance

- Have no pre-existing musculoskeletal disorders

- Participate in the three-week supplement wash out prior to beginning the experiment (except for basic protein supplements and multivitamins)

Exclusion Criteria:

- Female

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
T+ Supplement
Randomized, placebo-controlled, double blind protocol with two treatment groups (matched by lean body mass). Group 1 will receive the recommended serving of one scoop (11g) of T+ supplement. This serving will be taken 45 minutes before the beginning of working out on an empty stomach (>1 hour after meal). On non-training days, the participants will also take a serving at the same time as on training days. This will continue for four weeks (28 days).
Placebo
The placebo group will consume a calorie-match placebo in the same manner as the supplement group (one serving 45 minutes prior to work outs on an empty stomach). The placebo group will also follow the same supplementation patterns and workout as their counterparts in the supplement group.

Locations

Country Name City State
United States Florida State University Tallahassee Florida

Sponsors (2)

Lead Sponsor Collaborator
Florida State University East Carolina University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Strength Performance Outcomes Measurement of one repetition maximums strength for all competition lifts included in a standard, ungeared, powerlifting competition (squat, bench, and deadlift). This testing will take place before the supplementation of either T+ or placebo and at the end of the four-week training period.
Each measure was only compared within it's own category against the baseline measurement and against that of the other group at the same time point.
Baseline measures and 4 weeks from start of study No
Primary Insulin Outcomes Measurements of insulin will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Blood Lipid Outcomes Measurements for blood lipid panels will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Total Testosterone Outcomes Measurements for testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Estrogen Outcomes Measurements for estrogen will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Insulin-like Growth Factor-I Outcomes Measurements for insulin-like growth factor-I will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Bio-availableTestosterone Outcomes Measurements for total testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Free Testosterone Outcomes Measurements for free testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Dihydrotestosterone Outcomes Measurements for dihydrotestosterone (DHT) will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training. Baseline, 2-week mark, 4-week mark Yes
Primary Cortisol Outcomes Baseline, 2-week mark, 4-week mark Yes
Primary Sex-hormone Binding Globulin Outcomes Baseline, 2-week mark, 4-week mark No
Primary Creatine-Kinase Outcomes Baseline, 2-week mark, 4-week mark Yes
Secondary Volume Performance Outcomes During the four weeks, the volume ((weight x reps)set 1+(weight x reps)set 2+ (weight x reps)set 3….. ) will be calculated and measured for each exercise in each lifting session. 4 Weeks No
See also
  Status Clinical Trial Phase
Completed NCT04065061 - Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations N/A
Completed NCT05304299 - Alleviating Effects Against High Intraocular Pressure by Oral Intake of Cordyceps Cicadae Mycelia N/A
Completed NCT04199234 - A Study to Compare the Tolerability of Microencapsulated Iron Compared to a Conventional Iron Supplement in the Market N/A
Completed NCT03769012 - Ability of Beta-glucan Supplementation to Augment Immune Function N/A
Completed NCT04063735 - Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia N/A